biospecimen__admin__batch_number	399.48.0
biospecimen__admin__bcr	Nationwide Children's Hospital
biospecimen__admin__day_of_dcc_upload	1
biospecimen__admin__disease_code	LIHC
biospecimen__admin__file_uuid	127A509B-791D-48DB-AD2A-A75B71359A88
biospecimen__admin__month_of_dcc_upload	7
biospecimen__admin__year_of_dcc_upload	2016
biospecimen__bio__bcr_analyte_barcode	TCGA-G3-AAV1-01A-11R
biospecimen__bio__bcr_portion_barcode	TCGA-G3-AAV1-01A-11
biospecimen__bio__bcr_sample_barcode	TCGA-G3-AAV1-01A
biospecimen__bio__biospecimen_barcode_bottom	0164104742
biospecimen__bio__day_of_creation	03
biospecimen__bio__day_of_shipment	26
biospecimen__bio__days_to_index	0
biospecimen__bio__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen__bio__is_derived_from_ffpe	NO
biospecimen__bio__month_of_creation	02
biospecimen__bio__month_of_shipment	03
biospecimen__bio__pathology_report_file_name	TCGA-G3-AAV1.0124A3C7-B294-464E-831D-3E4738E3F305.pdf
biospecimen__bio__plate_column	10
biospecimen__bio__plate_id	A38M
biospecimen__bio__plate_row	E
biospecimen__bio__quantity	3.40
biospecimen__bio__subportion_sequence	1
biospecimen__bio__vial_number	A
biospecimen__bio__volume	20.00
biospecimen__bio__year_of_creation	2014
biospecimen__bio__year_of_shipment	2014
biospecimen__shared__bcr_patient_barcode	TCGA-G3-AAV1
biospecimen__shared__patient_id	AAV1
clinical__ablation__ablation_performed_indicator	NO
clinical__ablation__bcr_ablation_barcode	TCGA-G3-AAV1-A62195
clinical__ablation__bcr_ablation_uuid	5D3B3242-0A08-41DA-BE37-6C1E9D3BE0AE
clinical__ablation__days_to_embolization_performed	231
clinical__ablation__embolization_performed_indicator	YES
clinical__ablation__embolization_type	Chemoembolization
clinical__ablation__embolizing_agent_utilized	Gelfoam
clinical__admin__day_of_dcc_upload	22
clinical__admin__file_uuid	1118AC1E-A3EA-48A6-B43B-10B32D80E485
clinical__admin__month_of_dcc_upload	12
clinical__admin__withdrawn	false
clinical__chol_lihc_shared__albumin_result_lower_limit	3.3
clinical__chol_lihc_shared__albumin_result_specified_value	3.2
clinical__chol_lihc_shared__albumin_result_upper_limit	4.8
clinical__chol_lihc_shared__bilirubin_lower_limit	0
clinical__chol_lihc_shared__bilirubin_upper_limit	0.7
clinical__chol_lihc_shared__child_pugh_classification_grade	B
clinical__chol_lihc_shared__creatinine_lower_level	0.6
clinical__chol_lihc_shared__creatinine_upper_limit	1.4
clinical__chol_lihc_shared__creatinine_value_in_mg_dl	0.7
clinical__chol_lihc_shared__fetoprotein_outcome_lower_limit	0
clinical__chol_lihc_shared__fetoprotein_outcome_upper_limit	10
clinical__chol_lihc_shared__fetoprotein_outcome_value	8
clinical__chol_lihc_shared__fibrosis_ishak_score	6 - Established Cirrhosis
clinical__chol_lihc_shared__hist_hepato_carc_fact	Hepatitis B
clinical__chol_lihc_shared__inter_norm_ratio_lower_limit	0.9
clinical__chol_lihc_shared__intern_norm_ratio_upper_limit	1.1
clinical__chol_lihc_shared__platelet_result_lower_limit	150
clinical__chol_lihc_shared__platelet_result_upper_limit	400
clinical__chol_lihc_shared__prothrombin_time_result_value	1.2
clinical__chol_lihc_shared__specimen_collection_method_name	Lobectomy
clinical__chol_lihc_shared__total_bilirubin_upper_limit	1.4
clinical__chol_lihc_shared__vascular_tumor_cell_type	Micro
clinical__clin_shared__age_at_initial_pathologic_diagnosis	51
clinical__clin_shared__bcr_followup_barcode	TCGA-G3-AAV1-F65936
clinical__clin_shared__bcr_followup_uuid	A6E14844-331A-473A-A0C8-D0BE38686E18
clinical__clin_shared__day_of_form_completion	14
clinical__clin_shared__days_to_initial_pathologic_diagnosis	0
clinical__clin_shared__eastern_cancer_oncology_group	1
clinical__clin_shared__informed_consent_verified	YES
clinical__clin_shared__lost_follow_up	NO
clinical__clin_shared__month_of_form_completion	7
clinical__clin_shared__person_neoplasm_cancer_status	WITH TUMOR
clinical__clin_shared__platelet_result_count	115
clinical__clin_shared__post_op_ablation_embolization_tx	NO
clinical__clin_shared__postoperative_rx_tx	NO
clinical__clin_shared__radiation_therapy	NO
clinical__clin_shared__residual_tumor	R0
clinical__clin_shared__tissue_prospective_collection_indicator	YES
clinical__clin_shared__tissue_retrospective_collection_indicator	NO
clinical__clin_shared__tumor_tissue_site	Liver
clinical__clin_shared__viral_hepatitis_serology	Hepatitis  C Antibody
clinical__clin_shared__year_of_form_completion	2014
clinical__clin_shared__year_of_initial_pathologic_diagnosis	2013
clinical__lihc__adjacent_hepatic_tissue_inflammation_extent_type	Severe
clinical__lihc_nte__new_tumor_event_ablation_embo_tx	Yes
clinical__lihc_nte__new_tumor_event_liver_transplant	No
clinical__nte__additional_pharmaceutical_therapy	NO
clinical__nte__additional_radiation_therapy	NO
clinical__nte__days_to_new_tumor_event_after_initial_treatment	49
clinical__nte__new_neoplasm_event_occurrence_anatomic_site	Liver
clinical__nte__new_neoplasm_event_type	Locoregional Recurrence
clinical__nte__new_tumor_event_additional_surgery_procedure	NO
clinical__nte__new_tumor_event_after_initial_treatment	YES
clinical__shared__histological_type	Hepatocellular Carcinoma
clinical__shared__history_of_neoadjuvant_treatment	No
clinical__shared__neoplasm_histologic_grade	G3
clinical__shared__other_dx	No
clinical__shared_stage__pathologic_m	M0
clinical__shared_stage__pathologic_n	N0
clinical__shared_stage__pathologic_t	T4
clinical__shared_stage__system_version	7th
gdc__access	open
gdc__acl	open
gdc__aliquots__aliquot_id	ba5ac2fb-983d-4b35-9ce1-8a6493c164d4
gdc__aliquots__concentration	0.17
gdc__aliquots__source_center	23
gdc__aliquots__submitter_id	TCGA-G3-AAV1-01A-11R-A38M-13
gdc__aliquots__updated_datetime	2018-09-06T14:13:07.098771-05:00
gdc__analysis__analysis_id	741861f2-f507-4940-b4ed-d7e905d7c7a2
gdc__analysis__workflow_link	https://github.com/NCI-GDC/gdc-dnaseq-cwl/blob/gdc-active-submission/workflows/mirnaseq/runner.cwl
gdc__analysis__workflow_type	BCGSC miRNA Profiling
gdc__analytes__a260_a280_ratio	1.96
gdc__analytes__analyte_id	5b88961e-f19b-432a-a49a-8a4b2d93239b
gdc__analytes__analyte_type	RNA
gdc__analytes__analyte_type_id	R
gdc__analytes__spectrophotometer_method	UV Spec
gdc__case_id	ee6d81bf-0470-4652-aff0-d85f6ab67626
gdc__center__center_id	6eba705a-0f00-5aa2-b1d0-04dbf62100cc
gdc__center__center_type	CGCC
gdc__center__code	13
gdc__center__name	Canada's Michael Smith Genome Sciences Centre
gdc__center__namespace	bcgsc.ca
gdc__center__short_name	BCGSC
gdc__created_datetime	2018-03-20T12:32:47.609868-05:00
gdc__data_category	Transcriptome Profiling
gdc__data_format	TXT
gdc__data_type	miRNA Expression Quantification
gdc__demographic__demographic_id	a4606ce8-84c5-5473-a7bc-6bf01a893cfa
gdc__demographic__ethnicity	not hispanic or latino
gdc__demographic__gender	male
gdc__demographic__race	asian
gdc__demographic__year_of_birth	1962
gdc__demographic__year_of_death	2013
gdc__diagnoses__age_at_diagnosis	18973
gdc__diagnoses__classification_of_tumor	not reported
gdc__diagnoses__days_to_birth	-18973.0
gdc__diagnoses__days_to_death	359.0
gdc__diagnoses__diagnosis_id	a6abc2fc-b447-5cbb-98a6-70c4f70fa60f
gdc__diagnoses__last_known_disease_status	not reported
gdc__diagnoses__morphology	8170/3
gdc__diagnoses__primary_diagnosis	Hepatocellular carcinoma NOS
gdc__diagnoses__prior_malignancy	not reported
gdc__diagnoses__progression_or_recurrence	not reported
gdc__diagnoses__site_of_resection_or_biopsy	Liver
gdc__diagnoses__tissue_or_organ_of_origin	Liver
gdc__diagnoses__tumor_grade	not reported
gdc__diagnoses__tumor_stage	stage iiic
gdc__diagnoses__vital_status	dead
gdc__disease_type	Adenomas and Adenocarcinomas
gdc__experimental_strategy	miRNA-Seq
gdc__exposures__bmi	30.218857788223804
gdc__exposures__exposure_id	e9139429-2720-529b-9c7f-5c5dd368508b
gdc__exposures__height	181.0
gdc__exposures__weight	99.0
gdc__file_id	c2a72742-0953-443e-9f8e-6dc3c4920bf0
gdc__file_name	93eee06c-72d2-4e9a-a22b-87778b4c670d.mirbase21.mirnas.quantification.txt
gdc__file_size	50098
gdc__input_files__data_category	Raw Sequencing Data
gdc__input_files__data_format	BAM
gdc__input_files__data_type	Aligned Reads
gdc__input_files__experimental_strategy	miRNA-Seq
gdc__input_files__platform	Illumina
gdc__md5sum	72405e0cf38e5a81d378d02969ecd96a
gdc__portions__is_ffpe	false
gdc__portions__portion_id	d64b2f03-d5b0-46e1-aa49-ec17ad7b8a7f
gdc__portions__portion_number	11
gdc__portions__weight	30.0
gdc__primary_site	Liver and intrahepatic bile ducts
gdc__program__dbgap_accession_number	phs000178
gdc__program__name	TCGA
gdc__program__program_id	b80aa962-9650-5110-b3eb-bd087da808db
gdc__project__disease_type	Liver Hepatocellular Carcinoma
gdc__project__primary_site	Liver
gdc__project__project_id	TCGA-LIHC
gdc__project__releasable	false
gdc__project__released	true
gdc__samples__days_to_collection	146
gdc__samples__initial_weight	470.0
gdc__samples__oct_embedded	true
gdc__samples__pathology_report_uuid	0124A3C7-B294-464E-831D-3E4738E3F305
gdc__samples__sample_id	ad535210-07ee-41a5-b9f7-8548e41df779
gdc__samples__sample_type	Primary Tumor
gdc__samples__sample_type_id	01
gdc__slides__percent_lymphocyte_infiltration	3.0
gdc__slides__percent_monocyte_infiltration	1.0
gdc__slides__percent_necrosis	0.0
gdc__slides__percent_neutrophil_infiltration	1.0
gdc__slides__percent_normal_cells	0.0
gdc__slides__percent_stromal_cells	15.0
gdc__slides__percent_tumor_cells	85.0
gdc__slides__percent_tumor_nuclei	85.0
gdc__slides__section_location	TOP
gdc__slides__slide_id	22fe3767-c049-4d92-9d67-482433338217
gdc__submitter_id	mirna_swap_dr11_148_MirnaExpression25377193-6c46-409d-8971-b293c0dabb9f_profiling
gdc__tissue_source_site__bcr_id	NCH
gdc__tissue_source_site__code	G3
gdc__tissue_source_site__name	Alberta Health Services
gdc__tissue_source_site__tissue_source_site_id	addd7b04-91a3-5179-99a5-cbff20df6bb4
gdc__treatments__treatment_id	17b79e7f-c95d-537d-93ce-a2a9dd0d72a8
gdc__type	mirna_expression
gdc__updated_datetime	2018-09-08T13:43:34.032262+00:00
manually_curated__data_format	BED
manually_curated__download_date	2018-11-06T09:10:45.558+01:00
manually_curated__exp_data_bed_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/ba5ac2fb-983d-4b35-9ce1-8a6493c164d4-meq.bed
manually_curated__exp_metadata_url	ftp://bioinformatics.iasi.cnr.it/opengdc/bed/tcga/tcga-lihc/mirna_expression_quantification/ba5ac2fb-983d-4b35-9ce1-8a6493c164d4-meq.bed.meta
manually_curated__genome_built	GRCh38
manually_curated__local_file_size	129469
manually_curated__local_md5	4096bbd5149437adbd7df58721c38e42
manually_curated__opengdc_download_date	2018-10-16T17:12:16.000243+02:00
manually_curated__opengdc_file_md5	1bb981fbbd320a516d6296b6dd38b74f
manually_curated__opengdc_file_size	50097
manually_curated__opengdc_id	ba5ac2fb-983d-4b35-9ce1-8a6493c164d4-meq
manually_curated__origin_file_size	129469
manually_curated__origin_last_modified_date	Tue Oct 16 17:26:00 CEST 2018
manually_curated__origin_md5	4096bbd5149437adbd7df58721c38e42
manually_curated__tissue_status	tumoral
